Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker MedSurg & Neurotechnology by Year
MedSurg & Neurotechnology — Selling Price Growth Impact YoY (%) (%)
Stryker MedSurg & Neurotechnology: 0.5% in FY2025, down 1.1 pts from a year earlier.
Latest, FY2025
0.5%
Period ended Dec 31, 2025
Change on a year earlier
-1.1 pts
1.6% in FY2024
History
6 years
Since FY2020
Sources
4
Documents cited below
Where the FY2025 figure comes from
“Excluding the 5.4% impact of acquisitions and divestitures, net sales in constant currency increased by 10.3% from increased unit volume and 0.5% due to higher prices.”
Reported in Stryker Form 10-Q & Form 10-K MD&A.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | MedSurg & Neurotechnology — Selling Price Growth Impact YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0.5% | -1.1 pts | 0000310764-26-000041|syk-20260626_d2.htm ↗ |
| FY2024 | Dec 31, 2024 | 1.6% | 0.0 pts | 0000310764-26-000041|syk-20260626_d2.htm ↗ |
| FY2023 | Dec 31, 2023 | 1.6% | +1.0 pts | 0000310764-24-000024|syk-20231231.htm ↗ |
| FY2022 | Dec 31, 2022 | 0.6% | +1.1 pts | 0000310764-23-000017|syk-20221231.htm ↗ |
| FY2021 | Dec 31, 2021 | -0.5% | -0.4 pts | 0000310764-22-000028|syk-20211231.htm ↗ |
| FY2020 | Dec 31, 2020 | -0.1% | – | 0000310764-22-000028|syk-20211231.htm ↗ |
Cite this data
StockData. (2026). Stryker MedSurg & Neurotechnology (%), annual FY2020–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/core-medsurg-price
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.